JNJ

186.79

+0.34%↑

ABT

125.77

+1.66%↑

TMO

565.15

+0.26%↑

ISRG

538.71

-0.99%↓

DHR

213.79

-0.14%↓

JNJ

186.79

+0.34%↑

ABT

125.77

+1.66%↑

TMO

565.15

+0.26%↑

ISRG

538.71

-0.99%↓

DHR

213.79

-0.14%↓

JNJ

186.79

+0.34%↑

ABT

125.77

+1.66%↑

TMO

565.15

+0.26%↑

ISRG

538.71

-0.99%↓

DHR

213.79

-0.14%↓

JNJ

186.79

+0.34%↑

ABT

125.77

+1.66%↑

TMO

565.15

+0.26%↑

ISRG

538.71

-0.99%↓

DHR

213.79

-0.14%↓

JNJ

186.79

+0.34%↑

ABT

125.77

+1.66%↑

TMO

565.15

+0.26%↑

ISRG

538.71

-0.99%↓

DHR

213.79

-0.14%↓

Search

Evolent Health Inc

Geschlossen

BrancheGesundheitswesen

6.51 -2.69

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

6.49

Max

6.86

Schlüsselkennzahlen

By Trading Economics

Einkommen

14M

-51M

Verkäufe

-39M

444M

Gewinnspanne

-11.498

Angestellte

4,500

EBITDA

43M

14M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+155.06% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

6. Nov. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-368M

779M

Vorheriger Eröffnungskurs

9.2

Vorheriger Schlusskurs

6.51

Nachrichtenstimmung

By Acuity

50%

50%

153 / 373 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Very Strong Bullish Evidence

Evolent Health Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

4. Nov. 2025, 23:57 UTC

Ergebnisse

Naver's Third-Quarter Earnings Rose on AI Push

4. Nov. 2025, 23:10 UTC

Akquisitionen, Fusionen, Übernahmen

Kennedy-Wilson Gets Acquisition Proposal From CEO, Fairfax Financial

4. Nov. 2025, 23:48 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

4. Nov. 2025, 23:48 UTC

Market Talk

Nikkei May Fall After U.S. Tech Stock Weakness -- Market Talk

4. Nov. 2025, 23:37 UTC

Market Talk

Gold Edges Higher on Possible Technical Recovery -- Market Talk

4. Nov. 2025, 23:30 UTC

Ergebnisse

Itau Unibanco 3Q Net BRL33.7B >ITUB

4. Nov. 2025, 23:25 UTC

Ergebnisse

Naver 3Q Net Profit Beat FactSet-Compiled Consensus

4. Nov. 2025, 23:25 UTC

Ergebnisse

Naver 3Q Net KRW734.70B Vs. Net KRW530.10B >035420.SE

4. Nov. 2025, 23:24 UTC

Ergebnisse

Naver 3Q Oper Pft KRW570.60B Vs. Pft KRW525.30B >035420.SE

4. Nov. 2025, 23:23 UTC

Ergebnisse

Naver 3Q Rev KRW3.138T Vs. KRW2.716T >035420.SE

4. Nov. 2025, 23:06 UTC

Ergebnisse

Review & Preview: Tech Check -- Barrons.com

4. Nov. 2025, 22:52 UTC

Ergebnisse

AMD Reports Sharply Higher Profits, Sales -- 3rd Update

4. Nov. 2025, 22:33 UTC

Ergebnisse

AMD Beats Earnings. The Stock Still Slides. -- Barrons.com

4. Nov. 2025, 22:29 UTC

Ergebnisse

Ashland 4Q Adj EPS $1.08 >ASH

4. Nov. 2025, 22:29 UTC

Ergebnisse

Ashland Sees FY26 Adjusted EPS Up More Than Double Digits >ASH

4. Nov. 2025, 22:28 UTC

Ergebnisse

Ashland Sees FY26 Sales $1.84B-$1.91B >ASH

4. Nov. 2025, 22:27 UTC

Ergebnisse

Ashland 4Q Cont Ops EPS 73c >ASH

4. Nov. 2025, 22:27 UTC

Ergebnisse

Ashland 4Q EPS 71c >ASH

4. Nov. 2025, 22:27 UTC

Ergebnisse

Ashland 4Q Sales $478M >ASH

4. Nov. 2025, 22:23 UTC

Ergebnisse

Ovintiv 3Q EPS 57c >OVV

4. Nov. 2025, 22:19 UTC

Market Talk

Canada Budget: Snap Election Talk Might Cool -- Market Talk

4. Nov. 2025, 22:16 UTC

Ergebnisse

AMD Reports Sharply Higher Profits, Sales -- 2nd Update

4. Nov. 2025, 22:14 UTC

Akquisitionen, Fusionen, Übernahmen

Kennedy-Wilson Board Forms Special Committee to Evaluate Proposal

4. Nov. 2025, 22:13 UTC

Akquisitionen, Fusionen, Übernahmen

Consortium: Not Interested in Selling Kennedy-Wilson Shares to Another Party

4. Nov. 2025, 22:13 UTC

Akquisitionen, Fusionen, Übernahmen

Consortium: Able to Finance a Deal With Available Liquidity

4. Nov. 2025, 22:12 UTC

Akquisitionen, Fusionen, Übernahmen

Consortium Owns About 31% of Kennedy-Wilson Stock on As-Converted Basis

4. Nov. 2025, 22:11 UTC

Ergebnisse

Private-Credit Earnings Ease Investor Concern Over Market's Health -- Update

4. Nov. 2025, 22:11 UTC

Akquisitionen, Fusionen, Übernahmen

Kennedy-Wilson Gets Proposal From CEO William McMorrow and Fairfax Financial Holdings

4. Nov. 2025, 22:10 UTC

Akquisitionen, Fusionen, Übernahmen

Pfizer, Novo Nordisk Escalate Bidding War for Weight-Loss Drug Startup -- 2nd Update

4. Nov. 2025, 22:07 UTC

Ergebnisse

Kinross Gold Raises Dividend to $0.035 >K.T

Peer-Vergleich

Kursveränderung

Evolent Health Inc Prognose

Kursziel

By TipRanks

155.06% Vorteil

12-Monats-Prognose

Durchschnitt 17.14 USD  155.06%

Hoch 20 USD

Tief 14 USD

Basierend auf 11 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Evolent Health Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

11 ratings

11

Buy

0

Halten

0

Sell

Technischer Score

By Trading Central

10.33 / 10.95Unterstützung & Widerstand

Kurzfristig

Very Strong Bullish Evidence

Mittelfristig

Very Strong Bullish Evidence

Langfristig

Weak Bearish Evidence

Stimmung

By Acuity

153 / 373 Ranking in Gesundheitswesen

Nachrichtenstimmung

Neutral

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Evolent Health Inc

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
help-icon Live chat